Advanced Search

 

Study ID Status Title Patient Level Data
116287 Completed An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety of KIVEXA(abacavir/lamivudine) administered in Korean patients according to the prescribing information
205846 Not yet recruiting PRJ2693: Descriptive Analysis of Neuropsychiatric Diagnoses in Patients taking Dolutegravir in the OPERA® Observational Database
205892 Terminated A Phase 2b Randomized, Active-Controlled, Staged, Open-Label Trial to Investigate Safety and Efficacy of BMS-955176/GSK3532795 in Combination with Dolutegravir and Atazanavir (with or without Ritonavir) in Treatment-Experienced HIV-1 Infected Adults
206206 Not yet recruiting Rates of Suspected Hypersensitivity Reaction to Abacavir and Associated Rates of HLA-B*5701 Testing
206242 Not yet recruiting Prenatal Exposure to Dolutegravir and Pregnancy and Neonatal Outcomes: Data from Antiretroviral Pregnancy Registry
206247 Not yet recruiting Post-marketing safety analyses for multiple marketed products in collaboration with the D:A:D study
206254 Completed Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir: Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
206307 Not yet recruiting Abacavir Usage Patterns and Trends in Hypersensitivity Reactions (HSR) in the EuroSIDA cohort
207263 Active, not recruiting Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Meta-analysis of Data from Clinical Trials
207831 Not yet recruiting Rates of Suspected Hypersensitivity Reaction in HIV infected Adult treatment populations screened HLA-B*5701 negative prior to commencing Abacavir therapy: Meta-analysis of Data from GlaxoSmithKline and ViiV Healthcare Sponsored Clinical Trials
207833 Not yet recruiting Comparison of Dolutegravir Effectiveness vs. Other Core Agent Effectiveness among Hepatitis C Virus Co-infected patients in the OPERA® Observational Database
207919 Not yet recruiting An assessment of two-drug regimens (2DR) with respect to regimen durability among HIV Positive Patients in the EuroSIDA cohort
208613 Not yet recruiting DOLOMITE EPPICC Study: Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir: Data from the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)